List view / Grid view
30 June 2015 | By Victoria White
MSD recently announced the primary results of the TECOS trial, a placebo-controlled study of the cardiovascular safety of MSD’s DPP-4 inhibitor, sitagliptin...
30 June 2015 | By Victoria White
The global biosimilars market value is expected to reach $20 billion by the end of 2015 and could hit $55 billion by 2020, according to GBI Research...
30 June 2015 | By Victoria White
Roche has announced positive results from two studies evaluating ocrelizumab compared with interferon beta-1a in people with relapsing multiple sclerosis...
29 June 2015 | By Victoria White
Merck has announced results from a Phase 3 study investigating single-dose Emend for Injection for the prevention of CINV associated with MEC...
Laboratories performing food safety and authenticity, pharmaceutical, metabolomic, anti-doping and other analyses using gas chromatography-mass spectrometry (GC-MS) can now achieve new levels of performance using high-resolution accurate-mass (HRAM) Orbitrap mass spectrometry, bringing the highest level of detection and identification capabilities to GC-MS studies.
New Tribrid Mass Spectrometer with improved sensitivity redefines the limits of protein and small molecule quantitation and characterization...
New, exceptionally pure mobile phase solvents for ultra-high-performance liquid chromatography–mass spectrometry (UHPLC-MS) instruments have been designed to reduce background signal and minimize chromatographic interferences, facilitating accurate, sensitive and rapid trace analysis.
29 June 2015 | By Victoria White
Public health officials have blamed the waning effectiveness of the current vaccine and anti-vaccine sentiment as the cause of the whooping cough resurgence...
Zealand has announced results from a clinical Phase I trial with a single-dose version of its novel, stable glucagon analogue, ZP4207.
29 June 2015 | By Victoria White
Sirius Scissor is an instrument designed to mimic the stresses a treatment experiences when transitioning from formulation conditions to a SC environment...
29 June 2015 | By Victoria White
The European Commission (EC) has approved the oral suspension formulation of Sobi’s Orfadin for the treatment of Hereditary Tyrosinaemia type-1 (HT-1)...
29 June 2015 | By Victoria White
The Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorisation in the EU for CSL Behring's Respreeza...
29 June 2015 | By Victoria White
The CHMP has recommended that the EC approves the use of Perjeta for the neoadjuvant treatment of adult patients with HER2-positive early breast cancer...
29 June 2015 | By Victoria White
New one year results from the pivotal Phase III FUTURE 2 study of Novartis’ secukinumab in psoriatic arthritis (PsA) have been published.
29 June 2015 | By Victoria White
Novartis has entered into an agreement to acquire Spinifex - a company focused on developing a peripheral approach to treat neuropathic pain...
